Literature DB >> 10763399

Direct and indirect randomized trials of screening: the A's and D's of evidence-based clinical practice guidelines.

J Mahon1.   

Abstract

Mesh:

Year:  2000        PMID: 10763399      PMCID: PMC1232304     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  14 in total

1.  Preventive medicine in people at high risk for chronic disease: the value of identifying and treating diabetes.

Authors:  H C Gerstein; S Meltzer
Journal:  CMAJ       Date:  1999-06-01       Impact factor: 8.262

2.  Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia.

Authors:  R C Eastman; J C Javitt; W H Herman; E J Dasbach; C Copley-Merriman; W Maier; F Dong; D Manninen; A S Zbrozek; J Kotsanos; S A Garfield; M Harris
Journal:  Diabetes Care       Date:  1997-05       Impact factor: 19.112

Review 3.  Management of diabetes mellitus from a public health perspective.

Authors:  S H Roman; M I Harris
Journal:  Endocrinol Metab Clin North Am       Date:  1997-09       Impact factor: 4.741

4.  Assessing the clinical effectiveness of preventive maneuvers: analytic principles and systematic methods in reviewing evidence and developing clinical practice recommendations. A report by the Canadian Task Force on the Periodic Health Examination.

Authors:  S H Woolf; R N Battista; G M Anderson; A G Logan; E Wang
Journal:  J Clin Epidemiol       Date:  1990       Impact factor: 6.437

Review 5.  An epidemiological perspective on cancer screening.

Authors:  A B Miller
Journal:  Clin Biochem       Date:  1995-02       Impact factor: 3.281

6.  Prevention of nonvertebral fractures by alendronate. A meta-analysis. Alendronate Osteoporosis Treatment Study Groups.

Authors:  D B Karpf; D R Shapiro; E Seeman; K E Ensrud; C C Johnston; S Adami; S T Harris; A C Santora; L J Hirsch; L Oppenheimer; D Thompson
Journal:  JAMA       Date:  1997-04-09       Impact factor: 56.272

Review 7.  Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of essential hypertension.

Authors:  R I Ogilvie; E D Burgess; J R Cusson; R D Feldman; L A Leiter; M G Myers
Journal:  CMAJ       Date:  1993-09-01       Impact factor: 8.262

8.  Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.

Authors:  M Ravid; R Lang; R Rachmani; M Lishner
Journal:  Arch Intern Med       Date:  1996-02-12

9.  Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

Authors:  Y Ohkubo; H Kishikawa; E Araki; T Miyata; S Isami; S Motoyoshi; Y Kojima; N Furuyoshi; M Shichiri
Journal:  Diabetes Res Clin Pract       Date:  1995-05       Impact factor: 5.602

10.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.